- In April 2023, Pfizer Inc. launched a novel formulation of Advil Dual Action in the U.S., combining ibuprofen and acetaminophen in a single tablet for enhanced multi-symptom pain relief. This innovation addresses consumer demand for more effective OTC solutions and reinforces Pfizer’s position as a leader in consumer healthcare by offering a simplified, yet powerful pain management option for everyday use
- In March 2023, Johnson & Johnson Consumer Health introduced a digital pain tracking app in Europe designed to complement its Tylenol and Motrin product lines. The app enables users to monitor pain intensity, frequency, and triggers, offering personalized product recommendations and improving medication adherence. This advancement highlights the company’s focus on digital health integration and patient-centered care in the analgesics space
- In March 2023, Haleon plc, the consumer health spin-off from GSK, expanded its Panadol range in Asia-Pacific with the launch of Panadol UltraPro. This new formulation is specifically designed to deliver fast-acting relief from moderate to severe pain, targeting growing urban populations experiencing lifestyle-related discomfort. The move supports Haleon’s strategy to deepen regional market penetration through targeted innovation
- In February 2023, Bayer AG announced a strategic collaboration with One Drop, a digital health company, to develop data-driven insights for chronic pain management using Bayer’s Aleve product line. The initiative aims to integrate real-time monitoring with personalized pain relief strategies, reflecting Bayer’s commitment to advancing digital therapeutics and holistic care in the analgesics market
- In January 2023, Teva Pharmaceuticals introduced a generic version of Celebrex (celecoxib) in the U.S. market, significantly improving affordability for patients seeking prescription NSAID therapies. This launch enhances Teva’s already broad analgesics portfolio and aligns with its mission to increase access to essential medications while maintaining high standards of efficacy and safety
